Growth Metrics

Esperion Therapeutics (ESPR) Amortizatization of Intangibles (2018 - 2023)

Esperion Therapeutics' Amortizatization of Intangibles history spans 6 years, with the latest figure at -$100000.0 for Q2 2023.

  • For Q2 2023, Amortizatization of Intangibles rose 50.0% year-over-year to -$100000.0; the TTM value through Mar 2024 reached -$100000.0, down 150.25%, while the annual FY2023 figure was $412000.0, 247.67% up from the prior year.
  • Amortizatization of Intangibles reached -$100000.0 in Q2 2023 per ESPR's latest filing, down from $339000.0 in the prior quarter.
  • In the past five years, Amortizatization of Intangibles ranged from a high of $339000.0 in Q1 2023 to a low of -$200000.0 in Q3 2019.
  • Average Amortizatization of Intangibles over 5 years is -$27000.0, with a median of -$100000.0 recorded in 2019.
  • Peak YoY movement for Amortizatization of Intangibles: crashed 300.0% in 2019, then surged 2266.67% in 2022.
  • A 5-year view of Amortizatization of Intangibles shows it stood at $60000.0 in 2019, then tumbled by 266.67% to -$100000.0 in 2020, then surged by 88.0% to -$12000.0 in 2021, then soared by 2266.67% to $260000.0 in 2022, then tumbled by 138.46% to -$100000.0 in 2023.
  • Per Business Quant, the three most recent readings for ESPR's Amortizatization of Intangibles are -$100000.0 (Q2 2023), $339000.0 (Q1 2023), and $260000.0 (Q4 2022).